Avacta Therapeutics (AIM: AVCT) has appointed experienced biotechnology finance executive Mats Blom to its Board of Directors, where he will also serve as Chair of the Audit Committee.
Avacta Therapeutics (AIM: AVCT) has appointed experienced biotechnology finance executive Mats Blom to its Board of Directors, where he will also serve as Chair of the Audit Committee.
Avacta Therapeutics (AVCT), a clinical stage biopharmaceutical company developing pre|CISION®, a tumor-activated oncology delivery platform, today announced the appointment of the seasoned biotech executive Mr. Mats Blom as a member of
BBC: Argentine leader threatens to sanction oil firms (RKH, BOR) and reiterates Falklands claim. Argentina’s president has heightened tensions with the UK over the Falkland Islands, warning he will impose economic
Avacta Therapeutics (AIM: AVCT) has settled an accelerated deferred convertible bond repayment of £2.613 million in cash, reducing the remaining principal under the facility to £12 million.
Avacta (AIM: AVCT) has granted a substantial package of share options to its management team, including 13.4 million options to chief executive Christina Coughlin, as part of an incentive and
FTSE 100 Closes Higher as Vodafone Surges 13% and easyJet Jumps on Apollo Bid 📈 The FTSE 100 ended higher on Friday in calmer trading, helped by a double-digit rise
Zak Mir takes a charting look at some of the latest requested stocks, including Avacta, easyJet, Fulcrum Metals, First Class, Panther Metals, and Quantum Helium.
Accelerated Amortized Payment of Convertible Bond Installment
Union Jack Oil plc (UJO), acknowledges the receipt of a requisition notice dated 7 July 2026 from shareholders who hold 20,650,096 ordinary shares in the Company representing 14.09% of the total voting
Avacta Therapeutics (AIM: AVCT) has appointed healthcare executive Dr Patrick Vink to its board as non-executive deputy chairman and senior independent director.
London’s leading stock indices ended the week on a subdued note, with the FTSE 100 edging lower after briefly trading near a two-month high. The blue-chip index closed down 21.87
Quantum Helium Limited (QHE) provided shareholders with a review of the key milestones achieved over the past twelve months ahead of the Company’s Extraordinary General Meeting (“EGM”), which is scheduled to